Transcription Factor Sp1 Is Involved in Expressional Regulation of Coxsackie and Adenovirus Receptor in Cancer Cells

被引:5
|
作者
Chung, Sun-Ku [1 ,2 ]
Kim, Joo-Young [1 ,3 ]
Lim, Joong-Yeon [1 ]
Park, Young Mi [1 ]
Hwang, Ha-Young [1 ]
Nam, Jae-Hwan [4 ]
Park, Sang Ick [1 ]
机构
[1] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Cheongwon Gun 363951, Chungcheongbuk, South Korea
[2] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA
[3] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea
[4] Catholic Univ Korea, Dept Biotechnol, Gyeonggi Do 420743, Bucheon, South Korea
来源
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2011年
关键词
DEACETYLASE INHIBITOR FR901228; HUMAN BLADDER-CANCER; TRANSGENE EXPRESSION; MALIGNANT-CELLS; GROWTH; CAR; PROMOTER; BINDING;
D O I
10.1155/2011/636497
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Coxsackie and adenovirus receptor (CAR) was first known as a virus receptor. Recently, it is also known to have tumor suppressive activity such as inhibition of cell proliferation, migration, and invasion. It is important to understand how CAR expression can be regulated in cancers. Based on an existence of putative Sp1 binding site within CAR promoter, we investigated whether indeed Sp1 is involved in the regulation of CAR expression. We observed that deletion or mutation of Sp1 binding motif (-503/-498) prominently impaired the Sp1 binding affinity and activity of CAR promoter. Histone deacetylase inhibitor (TSA) treatment enhanced recruitment of Sp1 to the CAR promoter in ChIP assay. Meanwhile, Sp1 binding inhibitor suppressed the recruitment. Exogenous expression of wild-type Sp1 increased CAR expression in CAR-negative cells; meanwhile, dominant negative Sp1 decreased the CAR expression in CAR-positive cells. These results indicate that Sp1 is involved in regulation of CAR expression.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Hyperglycemia-driven dysregulation of Sp1 transcription factor in retinal cells
    Donovan, Kelly
    Alekseev, Oleg
    Clifford, Jane
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [32] REGULATION OF RAT ORNITHINE DECARBOXYLASE PROMOTER ACTIVITY BY BINDING OF TRANSCRIPTION FACTOR SP1
    KUMAR, AP
    MAR, PK
    ZHAO, BW
    MONTGOMERY, RL
    KANG, DC
    BUTLER, AP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) : 4341 - 4348
  • [33] Regulation of Transcription Factor SP1 by the β-Catenin Destruction Complex Modulates Wnt Response
    Mir, Rafeeq
    Sharma, Ankita
    Pradhan, Saurabh J.
    Galande, Sanjeev
    MOLECULAR AND CELLULAR BIOLOGY, 2018, 38 (22)
  • [34] Negative Regulation of DsbA-L Gene Expression by the Transcription Factor Sp1
    Fang, Qichen
    Yang, Wenjing
    Li, Huating
    Hu, Wenxiu
    Chen, Lihui
    Jiang, Shan
    Dong, Kun
    Song, Qianqian
    Wang, Chen
    Chen, Shuo
    Liu, Feng
    Jia, Weiping
    DIABETES, 2014, 63 (12) : 4165 - 4171
  • [35] Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor
    Li, J
    Ou, JH
    JOURNAL OF VIROLOGY, 2001, 75 (18) : 8400 - 8406
  • [36] Sp1 is a key regulator of the PDGF β-receptor transcription
    Catrin Molander
    Anders Hackzell
    Mitsuhiro Ohta
    Hiroto Izumi
    Keiko Funa
    Molecular Biology Reports, 2001, 28 : 223 - 233
  • [37] Sp1 transcription factor: A long-standing target in cancer chemotherapy
    Vizcaino, Carolina
    Mansilla, Sylvia
    Portugal, Jose
    PHARMACOLOGY & THERAPEUTICS, 2015, 152 : 111 - 124
  • [38] Regulation of the fibroblast growth factor receptor 3 promoter and intron I enhancer by Sp1 family transcription factors
    McEwen, DG
    Ornitz, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) : 5349 - 5357
  • [39] Sp1 is essential for estrogen receptor α gene transcription
    deGraffenried, LA
    Hilsenbeck, SG
    Fuqua, SAW
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 82 (01): : 7 - 18
  • [40] Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1α
    K Küster
    A Koschel
    N Rohwer
    A Fischer
    B Wiedenmann
    M Anders
    Cancer Gene Therapy, 2010, 17 : 141 - 146